Chongqing University Cancer Hospital

This study tests whether adding a low-dose chemotherapy pill (capecitabine) to standard chemoradiotherapy can improve outcomes for people with high-risk nasopharyngeal cancer. It includes 252 adults with stage T1-2N1M0 disease who have certain high-risk features. The goal is to s…

This study tests a treatment for people with nasopharyngeal cancer that has spread to other parts of the body. The treatment combines an immunotherapy drug (tislelizumab) with chemotherapy and radiation therapy that is adjusted based on how well the tumor responds. The goal is to…